These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8459622)

  • 1. [Statistical review of Malignant melanoma and its precancerous condition].
    Ueda M; Mishima Y
    Nihon Rinsho; 1993 Jan; 51 Suppl():852-60. PubMed ID: 8459622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statistical study of 623 cases of malignant cutaneous melanoma].
    Maillard GF
    Ann Dermatol Syphiligr (Paris); 1971; 98(1):5-20. PubMed ID: 4103132
    [No Abstract]   [Full Text] [Related]  

  • 3. Current concepts on malignant melanoma.
    Das Gupta TK
    Surg Annu; 1970; 2(0):183-206. PubMed ID: 4950801
    [No Abstract]   [Full Text] [Related]  

  • 4. [Round table on: Melanoma: problems of therapy].
    Minerva Chir; 1985 Jun; 40(12):921-42. PubMed ID: 4034005
    [No Abstract]   [Full Text] [Related]  

  • 5. [The surgery of malignant melanoma. Apropos 206 cases studied].
    Sierra García A
    An R Acad Nac Med (Madr); 1993; 110(2):321-37. PubMed ID: 8311200
    [No Abstract]   [Full Text] [Related]  

  • 6. [New factors in the clinical aspect of malignant cutaneous melanoma].
    Spitalier JM; Amalric R; Ayme Y; Lieutaud R
    Bull Cancer; 1970; 57(4):403-11. PubMed ID: 4996813
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma.
    van Egmond DB; Welvaart K; Hermans J; Ruiter DJ
    Neth J Surg; 1990 Apr; 42(2):43-6. PubMed ID: 2348926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
    Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant melanoma in childhood and adolescence.
    Melnik MK; Urdaneta LF; Al-Jurf AS; Foucar E; Jochimsen PR; Soper RT
    Am Surg; 1986 Mar; 52(3):142-7. PubMed ID: 3954260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB).
    Russell-Jones R; Powell AM; Acland K; Calonje E; O'Doherty M; Healy C
    Eur J Surg Oncol; 2005 Mar; 31(2):210-1. PubMed ID: 15698741
    [No Abstract]   [Full Text] [Related]  

  • 14. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
    Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE
    Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic variables for patients with stage III malignant melanoma.
    Messaris GE; Konstadoulakis MM; Ricaniadis N; Leandros E; Androulakis G; Karakousis PC
    Eur J Surg; 2000 Mar; 166(3):233-9. PubMed ID: 10755339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous melanoma--retrospective study of a small series of patients.
    Metcalf JS; Hawk JC; Kreutner A
    J S C Med Assoc; 1981 Mar; 77(3):113-7. PubMed ID: 6938740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognosis of patients with level V melanomas of the extremities].
    Krüger I; Ghussen F; Groth W
    Z Hautkr; 1989 Jul; 64(7):573-6. PubMed ID: 2773539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for lymph node metastasis in malignant melanoma].
    Mussack T; Waldner H; Kharraz-Tavakol A
    Zentralbl Chir; 1996; 121(6):465-8. PubMed ID: 8767332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.